WHX 2027 to spotlight UAE diabetes surge and metabolic health

New IDF data projecting a 47% rise in UAE diabetes cases by 2050 will anchor a longevity and metabolic health programme at January's World

WHX 2027 to spotlight UAE diabetes surge and metabolic health

The World Health Expo (WHX), taking place in Dubai from 25 to 28 January 2027, will dedicate a two-day programme to longevity and preventive health, using projections from the International Diabetes Federation (IDF) to frame the debate. The IDF's Diabetes Atlas forecasts that the number of adults aged 20 to 79 living with diabetes in the UAE will climb from approximately 1.3 million today to 1.9 million by 2050, a 47% increase that organisers say underscores the urgency of systemic, preventive intervention.

The figures sit within a broader public-health picture drawn from the UAE National Health and Nutrition Survey 2024–2025, published by the Ministry of Health and Community Protection in January 2026. That survey found that 59.1% of UAE adults do not meet recommended physical activity levels, 22.4% are living with obesity, and 25.9% have hypertension. The Ministry has already launched a national pre-diabetes and diabetes screening campaign alongside a non-communicable disease action plan, and the WHX programme is positioned as a complement to those efforts rather than a standalone initiative.

Healthspan Stage

The expo's Healthspan Stage will host a session titled "The GCC Metabolic Health Challenge: What Can We Change Now?", examining the interlocking effects of obesity, diabetes, physical inactivity, poor sleep and chronic stress. Speakers are expected to address what hospitals, employers, insurers and individuals can practically implement within a two-year horizon.

Dr Mushkaat Shahata, vice president of the Emirates Society of Lifestyle and Longevity Medicine and head of medical affairs at Omix Precision Health UAE, and a member of the Healthspan Stage advisory board, said the greatest gains come from integrated support rather than isolated clinical encounters. "Early risk detection must be followed by coordinated care that supports lasting change, alongside appropriate clinical treatment when needed," she said.

A second strand on the first day will examine how genomics, blood biomarkers, imaging and wearable-device data can be used for early risk detection and personalised prevention. Organisers say the programme draws on a Frost and Sullivan report from October 2026, which identified clinical validation, integrated health data, and payment models that reward prevention as the main enablers of broader adoption of longevity medicine.

Market context

The Gulf Cooperation Council is an increasingly active market for preventive and longevity-focused health services, driven by a combination of high non-communicable disease burden, government-led diversification away from oil revenues, and a growing private-pay middle class. A number of clinics and digital-health platforms have entered the region offering metabolic testing, continuous glucose monitoring and lifestyle-medicine programmes, though the sector remains fragmented and largely unregulated at the longevity-services level.

Soline Singer, senior vice president for healthcare at inD, the joint venture between Informa PLC and Dubai World Trade Centre that organises WHX, said scaling longevity services will depend on offering clinically grounded, affordable care. "Connecting metabolic health to hospital, workplace, insurance and investment discussions will be central to expanding preventive care to more people," she said.

The expo's second day turns to lifestyle and enabling factors: women's mid-life health, muscle strength and physical independence, the value of wearable data, and the role of real-estate developers in creating environments that support active ageing. WHX is also launching a dedicated longevity and wellness exhibition zone within the Dubai World Trade Centre venue to connect precision-health and preventive-care companies with healthcare procurement decision-makers.